Cepheid Announces Analyst Event And Webcast

News provided by

Jun 09, 2015, 07:00 ET

SUNNYVALE, Calif., June 9, 2015 /PRNewswire/ -- Cepheid (Nasdaq: CPHD) today announced that the company will host a Financial Analyst Event on Monday, July 27^th at the 2015 AACC Meeting being held July 26^th to 30^th in Atlanta, GA.

The meeting will feature presentations and Q&A sessions with Cepheid's executive management team, and include a review of Cepheid's oncology program, the annual update of the company's five year test menu pipeline, and other subjects. Meeting registration is now open to institutional investors and analysts.

When	4pm ET on Monday, July 27^th
Where	Omni Atlanta Hotel at CNN Center
RSVP	[email protected]

Interested parties unable to attend in person are invited to access the live webcast starting at 4 p.m. Eastern Time on Monday, July 27^th. To access the webcast, please visit Cepheid's website at http://ir.cepheid.com. A replay of the webcast will be available shortly following the event and will remain available for at least 90 days.

About Cepheid

Based in Sunnyvale, Calif., Cepheid (Nasdaq: CPHD) is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy to use molecular systems and tests. By automating highly complex and time-consuming manual procedures, the company's solutions deliver a better way for institutions of any size to access the full power of molecular diagnostics. The company's systems enable rapid, sophisticated testing solutions for infectious diseases, oncology, and genetic conditions by automating otherwise complex manual laboratory procedures. Through its strong molecular biology capabilities, the company is focusing on those applications where accurate, rapid, and actionable test results are needed most, such as managing infectious diseases and cancer. For more information, visit www.cepheid.com.

For Cepheid Media & Investor Inquiries:
Jacquie Ross, CFA
Cepheid Corporate Communications & Investor Relations
408-400-8329
[email protected]

SOURCE Cepheid